Literature DB >> 28222076

Systematic Review of Hospital Readmissions Among Patients With Cancer in the United States.

Janice F Bell1, Robin L Whitney2, Sarah C Reed1, Hermine Poghosyan3, Rebecca S Lash4, Katherine K Kim1, Andra Davis5, Richard J Bold6, Jill G Joseph1.   

Abstract

PURPOSE/
OBJECTIVES: To review the existing literature on readmission rates, predictors, and reasons for readmission among adults with cancer.
. DATA SOURCES: U.S.-based empirical studies reporting readmission rates from January 2005 to December 2015 were identified using four online library databases-PubMed, CINAHL®, EconLit, and the online bibliography of the National Cancer Institute's Surveillance Epidemiology and End Results Program. Some articles were identified by the authors outside the database and bibliography searches. 
. DATA SYNTHESIS: Of the 1,219 abstracts and 271 full-text articles screened, 56 studies met inclusion criteria. The highest readmission rates were observed in patients with bladder, pancreatic, ovarian, or liver cancer. Significant predictors of readmission included comorbidities, older age, advanced disease, and index length of hospital stay. Common reasons for readmission included gastrointestinal and surgical complications, infection, and dehydration.
.
CONCLUSIONS: Clinical efforts to reduce the substantial readmission rates among adults with cancer may target high-rate conditions, infection prevention, proactive management of nausea and vomiting, and nurse-led care coordination interventions for older adult patients with multiple comorbid conditions and advanced cancer. 
. IMPLICATIONS FOR NURSING: Commonly reported reasons for readmission were nursing-sensitive
patient outcomes (NSPOs), amenable to nursing intervention in oncology settings. These findings underscore the important role oncology nurses play in readmission prevention by implementing evidence-based interventions to address NSPOs and testing their impact in future research.

Entities:  

Keywords:  clinical practice; nursing research quantitative; outcomes research

Mesh:

Year:  2017        PMID: 28222076     DOI: 10.1011/17.ONF.176-191

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  7 in total

1.  Patient portal adoption and use by hospitalized cancer patients: a retrospective study of its impact on adverse events, utilization, and patient satisfaction.

Authors:  Duaa Aljabri; Adrian Dumitrascu; M Caroline Burton; Launia White; Mahmud Khan; Sudha Xirasagar; Ronnie Horner; James Naessens
Journal:  BMC Med Inform Decis Mak       Date:  2018-07-27       Impact factor: 2.796

2.  Intercycle Unplanned Hospital Admissions Due to Cisplatin-based Chemotherapy Regimen-induced Adverse Reactions: A Retrospective Analysis.

Authors:  Heber Rew Bright; Sujith J Chandy; Raju Titus Chacko; Selvamani Backianathan
Journal:  Curr Drug Saf       Date:  2019

3.  Factors associated with healthcare utilisation during first year after cancer diagnose-a population-based study.

Authors:  Helena Ullgren; Lena Sharp; Anna Olofsson; Per Fransson
Journal:  Eur J Cancer Care (Engl)       Date:  2020-11-20       Impact factor: 2.520

4.  A quality improvement approach to reducing hospital readmissions in patients with cancer and heart failure.

Authors:  Anecita Fadol; Joylynmae Estrella; Valerie Shelton; Maryam Zaghian; Diane Vanbenschop; Valerie Counts; Tito R Mendoza; David Rubio; Patricia A Johnston
Journal:  Cardiooncology       Date:  2019-06-10

5.  Derivation and Validation of the Cancer READMIT Score: A Readmission Risk Scoring System for Patients With Solid Tumor Malignancies.

Authors:  Joanna-Grace M Manzano; Heather Lin; Hui Zhao; Josiah Halm; Maria E Suarez-Almazor
Journal:  JCO Oncol Pract       Date:  2021-08-06

6.  Improvement of the experience of colorectal cancer patients in Sweden with a regional cancer plan.

Authors:  A Sjövall; L Söderqvist; A Martling; C Buchli
Journal:  Colorectal Dis       Date:  2020-08-28       Impact factor: 3.917

7.  Thirty-day hospital readmission rate, reasons, and risk factors after acute inpatient cancer rehabilitation.

Authors:  Jegy M Tennison; Nahid J Rianon; Joanna G Manzano; Mark F Munsell; Marina C George; Eduardo Bruera
Journal:  Cancer Med       Date:  2021-07-27       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.